![Frontiers | Breast Cancer Classification Based on Tumor Budding and Stem Cell-Related Signatures Facilitate Prognosis Evaluation Frontiers | Breast Cancer Classification Based on Tumor Budding and Stem Cell-Related Signatures Facilitate Prognosis Evaluation](https://www.frontiersin.org/files/Articles/818869/fonc-11-818869-HTML/image_m/fonc-11-818869-g001.jpg)
Frontiers | Breast Cancer Classification Based on Tumor Budding and Stem Cell-Related Signatures Facilitate Prognosis Evaluation
![HE4 Overexpression by Ovarian Cancer Promotes a Suppressive Tumor Immune Microenvironment and Enhanced Tumor and Macrophage PD-L1 Expression | The Journal of Immunology HE4 Overexpression by Ovarian Cancer Promotes a Suppressive Tumor Immune Microenvironment and Enhanced Tumor and Macrophage PD-L1 Expression | The Journal of Immunology](https://www.jimmunol.org/sites/default/files/highwire/jimmunol/206/10.cover-source.jpg)
HE4 Overexpression by Ovarian Cancer Promotes a Suppressive Tumor Immune Microenvironment and Enhanced Tumor and Macrophage PD-L1 Expression | The Journal of Immunology
![Frontiers | Reprogramming of Tumor-Associated Macrophages with Anticancer Therapies: Radiotherapy versus Chemo- and Immunotherapies Frontiers | Reprogramming of Tumor-Associated Macrophages with Anticancer Therapies: Radiotherapy versus Chemo- and Immunotherapies](https://www.frontiersin.org/files/Articles/276127/fimmu-08-00828-HTML/image_m/fimmu-08-00828-g001.jpg)
Frontiers | Reprogramming of Tumor-Associated Macrophages with Anticancer Therapies: Radiotherapy versus Chemo- and Immunotherapies
![HE4 Overexpression by Ovarian Cancer Promotes a Suppressive Tumor Immune Microenvironment and Enhanced Tumor and Macrophage PD-L1 Expression | The Journal of Immunology HE4 Overexpression by Ovarian Cancer Promotes a Suppressive Tumor Immune Microenvironment and Enhanced Tumor and Macrophage PD-L1 Expression | The Journal of Immunology](https://www.jimmunol.org/content/jimmunol/206/10/2478/F2.large.jpg)
HE4 Overexpression by Ovarian Cancer Promotes a Suppressive Tumor Immune Microenvironment and Enhanced Tumor and Macrophage PD-L1 Expression | The Journal of Immunology
![HE4 Overexpression by Ovarian Cancer Promotes a Suppressive Tumor Immune Microenvironment and Enhanced Tumor and Macrophage PD-L1 Expression | The Journal of Immunology HE4 Overexpression by Ovarian Cancer Promotes a Suppressive Tumor Immune Microenvironment and Enhanced Tumor and Macrophage PD-L1 Expression | The Journal of Immunology](https://www.jimmunol.org/content/jimmunol/206/10/2478/F6.large.jpg)
HE4 Overexpression by Ovarian Cancer Promotes a Suppressive Tumor Immune Microenvironment and Enhanced Tumor and Macrophage PD-L1 Expression | The Journal of Immunology
![HE4 tumor marker concentration in neoplastic peritoneal effusion and in peritoneal fluid associated with benign gynecological diseases | Journal of Ovarian Research | Full Text HE4 tumor marker concentration in neoplastic peritoneal effusion and in peritoneal fluid associated with benign gynecological diseases | Journal of Ovarian Research | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2F1757-2215-7-22/MediaObjects/13048_2014_Article_240_Fig2_HTML.jpg)
HE4 tumor marker concentration in neoplastic peritoneal effusion and in peritoneal fluid associated with benign gynecological diseases | Journal of Ovarian Research | Full Text
![HE4 tumor marker concentration in neoplastic peritoneal effusion and in peritoneal fluid associated with benign gynecological diseases | Journal of Ovarian Research | Full Text HE4 tumor marker concentration in neoplastic peritoneal effusion and in peritoneal fluid associated with benign gynecological diseases | Journal of Ovarian Research | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2F1757-2215-7-22/MediaObjects/13048_2014_Article_240_Fig1_HTML.jpg)
HE4 tumor marker concentration in neoplastic peritoneal effusion and in peritoneal fluid associated with benign gynecological diseases | Journal of Ovarian Research | Full Text
Subtype-specific characterization of breast cancer invasion using a microfluidic tumor platform | PLOS ONE
![Markeri tumorali in bolile digestive 0758751841 Cabinet privat de gastroenterologie si hepatologie Bucuresti | 0758751841 Cabinet privat de gastroenterologie si hepatologie Bucuresti Markeri tumorali in bolile digestive 0758751841 Cabinet privat de gastroenterologie si hepatologie Bucuresti | 0758751841 Cabinet privat de gastroenterologie si hepatologie Bucuresti](https://i1.wp.com/www.hepatite.ro/wp-content/uploads/2019/02/Cancer-de-colon-simptome.jpg?resize=277%2C182)
Markeri tumorali in bolile digestive 0758751841 Cabinet privat de gastroenterologie si hepatologie Bucuresti | 0758751841 Cabinet privat de gastroenterologie si hepatologie Bucuresti
![Spitalul OncoFort – Ofera o sansa vietii tale | Spital Oncologic la nivel European - Markerii tumorali in screeningul cancerului Spitalul OncoFort – Ofera o sansa vietii tale | Spital Oncologic la nivel European - Markerii tumorali in screeningul cancerului](https://www.oncofort.ro/uploads/Articole/markeri-tumorali-tipuri-cancer-oncofort.jpg)
Spitalul OncoFort – Ofera o sansa vietii tale | Spital Oncologic la nivel European - Markerii tumorali in screeningul cancerului
![HE4 Overexpression by Ovarian Cancer Promotes a Suppressive Tumor Immune Microenvironment and Enhanced Tumor and Macrophage PD-L1 Expression | The Journal of Immunology HE4 Overexpression by Ovarian Cancer Promotes a Suppressive Tumor Immune Microenvironment and Enhanced Tumor and Macrophage PD-L1 Expression | The Journal of Immunology](https://www.jimmunol.org/content/jimmunol/206/10/2478/F1.large.jpg)
HE4 Overexpression by Ovarian Cancer Promotes a Suppressive Tumor Immune Microenvironment and Enhanced Tumor and Macrophage PD-L1 Expression | The Journal of Immunology
![Frontiers | From rough to precise: PD-L1 evaluation for predicting the efficacy of PD-1/PD-L1 blockades Frontiers | From rough to precise: PD-L1 evaluation for predicting the efficacy of PD-1/PD-L1 blockades](https://www.frontiersin.org/files/Articles/920021/fimmu-13-920021-HTML-r1/image_m/fimmu-13-920021-g001.jpg)